Non-Profit Trusted Source of Non-Commercial Health Information
The Original Voice of the American Academy of Anti-Aging, Preventative, and Regenerative Medicine
logo logo
Fdanews

Clinical Trials for Alzheimer’s Drugs Expand Targets, Group Says

7 months, 1 week ago

988  0
Posted on Nov 16, 2017, 12 p.m.

Disclaimer

The opinions of the authors, reviews by readers, healthcare professionals and those providing comments are theirs alone, and do not reflect the opinions of www.WorldHealth.net, any of its affiliates or any employee thereof. WorldHealth.net is not responsible for the accuracy of any of the information supplied by RSS feeds or by any other means from other sources.


Clinical Trials for Alzheimer’s Drugs Expand Targets, Group Says

This is a great report for the fight against Alzheimer's. 1 in 6 of us, and much higher in women, will not just be affected by but contract Alzheimer's. It's one of Anti-Aging Medicine's greatest enemies. In order to read this full article you need an FDA account. Don't worry it's free. I encourage everyone to read this exciting news from the FDA.
Dr. Jeff Winternheimer, D.C., Medical Editor
Contact
An Alzheimer’s research group offers positive news on clinical trials for Alzheimer’s drugs as well as suggestions for the way forward, in a new report.

Subscribe to our Newsletter

WorldHealth Videos